Efficient. Flexible. Cost-Effective.
Introducing the Aeroneb® Professional Nebulizer System
An exceptional aerosol delivery option for clinicians that saves time, lowers
costs and provides flexibility for respiratory therapy throughout the hospital.
The Aeroneb Pro provides effective dose delivery of physician-prescribedinhalation solutions for infants through adults requiring positive pressurebreathing assistance, including mechanical ventilation, as well as hand-heldnebulizer therapy. Utilizing Aerogen’s unique aerosol generator, theAeroneb Pro produces a fine particle, low velocity aerosol withoutenvironmentally unfriendly propellants, inefficient compressors or costlyultrasonic elements.
The Aeroneb Pro overcomes the issue of poor aerosol delivery duringmechanical ventilation, depositing up to four times more medicationthrough an endotracheal tube (in vitro) during mechanical ventilation thansmall volume nebulizers (SVNs). SVNs have been reported to deliverbetween 1–3%1 of the nominal dose to the lungs during mechanicalventilation, compared to 2–18%2 in nonintubated patients.
Performance Characteristics Table3
1CJ Harvey et al, European Respiratory Journal, 1997; 10: 905-909; 2GC Smaldone et al, Journal of Aerosol Medicine, Volume11, Number 2, 1998: pp. 113-125; 3Nebulization, 3 mL of 0.083% albuterol; 4MMAD: Mass Median Aerodynamic Diameter(micrometers); 5GSD: Geometric Standard Deviation; 6FPF: Fine Particle Fraction; 7Data on file at Aerogen, Inc.; 8Dosedeposited in vitro at endotracheal tube; Source: Fink JB, Schmidt D, Power J. Comparison of a nebulizer using a novel aerosolgenerator with a standard ultrasonic nebulizer designed for use during mechanical ventilation, ATS 2001. Medication Temperature/Time
Aeroneb Pro does not heat ordegrade medications.
Source: Fink JB, Schmidt D,Power J. Comparison of anebulizer using a novel aerosolgenerator with a standard emperatur

ultrasonic nebulizer designed foruse during mechanical ventilation,ATS 2001.
Time (minutes)
Efficient. Flexible. Cost-Effective.
• Maximizes respirable dose with 2.1 µm average MMAD, • Does not collect or nebulize condensate from ventilator • Unique aerosol generator does not heat or degrade Flexible
• Delivers all medications approved for use with standard Aerogen’s Aerosol Generator
• Operates inline with standard ventilator circuits and • Usable in the hospital, ambulatory clinics and during • Lightweight control module powered by AC or Cost-Effective
• Low residual volume in medication cup (average 0.3 mL • Multiple patient use• Autoclavable at 132ºC - 135ºC (270ºF - 275ºF) PRODUCT SPECIFICATIONS
Aeroneb® Professional Nebulizer System
Nebulizer Unit weight: 25 grams (0.9 oz.) Aeroneb® Professional (autoclavable) Nebulizer Unit
Control Module weight: 230 grams (8.1 oz.)Medication cup capacity: 10 mL Accessories and replacement parts available. For more product information,
visit Aerogen’s website at
Consumption: <6.5 watts (charging), <2.0 watts (nebulizing)
AC/DC adapter (input 100 to 240 VAC 50/60Hz, output 9 V)
or rechargeable battery (4.8 V nominal output)
Patient isolation: Approved to IEC 60601-1 and AAMI ES1
See Performance Characteristics Table
Noise level: Silent operation
Frequency, Nebulizer Unit: 128 kilohertz (kHz)
Configuration Options:
Aerogen (Ireland) Limited, Galway Business Park, Dangan, Ireland +353-91-502550 Aerogen, Inc. 2071 Stierlin Court, Mountain View, CA 94043 2002, Aerogen, Inc. All rights reserved. Aerogen and Aeroneb are registered trademarks of Aerogen, Inc.



Dionisios negros Estereotipos sexuales y orden racial en Colombia Mara Viveros Vigoya1 “Moreno soy, porque naci de la rumba y el sabor yo lo heredé del guaguancó”.2 INTRODUCCIÓN En Colombia como en el resto de América Latina (Bastide1970, Wade 1997, MutebaRahier 1998) la imagen oficial de la identidad nacional ha sido elaborada por las elitesblancas y blanco-mestizas en tor


AWMF-Leitlinien-Register Nr. 053/001k UrsachenHarnwegsinfekt (HWI); Pyelonephritis, Urethritis; außerdem Kolpitis, Prostatitis, ReizblasePatienten mit Pyelonephritis: Urosepsis (auch bei symptomarmem Verlauf, z. B. Kinder, geriatrischePatienten)Schwangere: Pyelonephritis, Urosepsis, FrühgeburtKinder: Nierenparenchymschäden, Niereninsuffizienz(Risiken der unerkannten Harnabflußstörung)F

Copyright © 2008-2018 All About Drugs